Korean Clinical Trials Prove Exosomes, Peptides and Spicules Outperforms Retinol in Anti-Ageing

• Modern Molecules introduces medical-grade skincare technology and the, revolutionary REGENEXâ„¢ Renewal Serum
• Using a technology originally developed to regenerate burned skin, the REGENEXâ„¢ complex is harnessed for the first time to regenerate aged skin back to youth.

SINGAPORE, Oct. 3, 2024 /PRNewswire/ -- Modern Molecules, in partnership with leading dermatologists from Seoul, Korea is proud to announce the global launch of its revolutionary anti-ageing solution: REGENEXâ„¢ Renewal Serum. Harnessing the power of medical-grade technology originally developed to regenerate and heal burns, this serum introduces a new category of medical cosmetics where healthcare innovation meets skincare aesthetics. Clinically proven to significantly outperform retinol, the REGENEXâ„¢ Renewal Serum redefines anti-ageing skincare aesthetics with its medical-grade, patent-pending REGENEXâ„¢ complex.

In clinical studies conducted by the Korean Skin Research Centre, REGENEX™ Renewal Serum demonstrated remarkable results, surpassing retinol by 7.2 times in wrinkle reduction and 17 times in diminishing pigmentation after just 8 weeks of use. The serum's cutting-edge formulation integrades exosomes, spicules, and peptides—ingredients originally used to regenerate burnt skin, these medical technologies are now repurposed to tackle signs of ageing. REGENEX™ Renewal Serum is the first product from Modern Molecules to utilise healthcare-derived technology in skincare.

REGENEXâ„¢: Backed by an Independent study from the Korean Skin Centre for unparalleled anti-ageing performance

REGENEXâ„¢ complex was discovered by the Modern Molecules research team, led by Dr Baek Ji Hwoon. Based in Seoul, Korea, the team boasts over 100 years of combined research experience and has published more than 200 peer-reviewed studies.

The REGENEXâ„¢ complex is clinically-proven to achieve:

• 7.2x better wrinkle reduction than retinol
• 17x better reduction in pigmentation and age spots
• Visible delay in ageing by an average of 5.5 years after 8 weeks of daily use
• 65% increase in collagen production within 2 weeks
• 33% reduction in wrinkles within the first 2 weeks

SINGAPORE, Oct. 3, 2024 /PRNewswire/ -- Modern Molecules, in partnership with leading dermatologists from Seoul, Korea is proud to announce the global launch of its revolutionary anti-ageing solution: REGENEXâ„¢ Renewal Serum. Harnessing the power of medical-grade technology originally developed to regenerate and heal burns, this serum introduces a new category of medical cosmetics where healthcare innovation meets skincare aesthetics. Clinically proven to significantly outperform retinol, the REGENEXâ„¢ Renewal Serum redefines anti-ageing skincare aesthetics with its medical-grade, patent-pending REGENEXâ„¢ complex.

In clinical studies conducted by the Korean Skin Research Centre, REGENEX™ Renewal Serum demonstrated remarkable results, surpassing retinol by 7.2 times in wrinkle reduction and 17 times in diminishing pigmentation after just 8 weeks of use. The serum's cutting-edge formulation integrades exosomes, spicules, and peptides—ingredients originally used to regenerate burnt skin, these medical technologies are now repurposed to tackle signs of ageing. REGENEX™ Renewal Serum is the first product from Modern Molecules to utilise healthcare-derived technology in skincare.

REGENEXâ„¢: Backed by an Independent study from the Korean Skin Centre for unparalleled anti-ageing performance

REGENEXâ„¢ complex was discovered by the Modern Molecules research team, led by Dr Baek Ji Hwoon. Based in Seoul, Korea, the team boasts over 100 years of combined research experience and has published more than 200 peer-reviewed studies.

The REGENEXâ„¢ complex is clinically-proven to achieve:

Other acclaimed skincare experts on the discovery panel include Australia-based dermatology skin influencer Dr Davin Lim (@drdavinlim) who has over 900k followers on both Instagram and YouTube, LinkedIn Beauty Top Voice cosmetic scientist Manessa Lormejuste and Singapore aesthetic doctor Dr Vicki Leong.

The complex combines three core technologies that work in tandem to reverse the effects of ageing:

• Exosomes: These powerful nanoparticles signal skin cells to regenerate and initiate the cell renewal process, boosting collagen production for plumper, more youthful skin.
• Spicules: Natural liquid microneedles create microchannels in the skin, allowing exosomes to penetrate deeper. Unlike most skincare products that remain on the surface, this technology regenerates skin from within, ensuring long-term results.
• Peptide Complex: Clinically proven wrinkle-reversal peptides are small proteins that smooth wrinkles and enhance skin elasticity, leading to younger, healthier-looking skin.

Dr. Baek, the Seoul-based dermatologist who led the development of the REGENEXâ„¢ technology, said: "REGENEXâ„¢ Renewal Serum represents a significant advancement in anti-ageing and delivers performance that has shown statistically significant superior efficacy versus retinol. It is an innovation that has been used to treat burn wounds with powerful regenerative properties. Harnessing this technology once used to regenerate burnt skin, we applied it to aged skin and were amazed to discover that it can trigger skin cell regeneration from deep within, reducing the appearance of wrinkles and pigmentation while improving overall skin texture."

Jo T, 33, a clinical trial participant, shared her experience: "As someone who's tried many anti-ageing products with little success, I was hesitant at first. Retinol has always irritated my skin, so I didn't expect much. But the REGENEX™ Renewal Serum surprised me right away. It felt light, absorbed quickly, and didn't leave my skin feeling greasy. Within two weeks, I started noticing my skin was changing. My skin felt firmer, and after eight weeks, the fine lines and wrinkles around my eyes and mouth had visibly reduced. What stood out most was how much smoother and younger my skin looked overall—like it had turned back the clock. I can confidently say this serum has made a huge difference in my routine, and I'll definitely be continuing with it."

Setting a New Standard in Anti-Ageing Technology 

REGENEXâ„¢ Renewal Serum is the result of decades of research and innovation from Modern Molecules' team of renowned dermatologists. More than just a skincare product, this serum represents a ground-breaking advancement in medical cosmetics, bringing healthcare technology originally developed to help burn victims regenerate new skin into the consumer skincare market. Designed to rejuvenate skin from the inside out, it effectively boosts collagen production, strengthens the skin barrier, and improves elasticity, providing visible, long-term anti-ageing results.

In five independent clinical studies, REGENEXâ„¢ Renewal Serum was shown to significantly outperform traditional retinol treatments. During a user trial involving 25 participants aged 30-52, all with varying degrees of visible ageing, key findings included:

• 89% agreed that REGENEXâ„¢ was more effective than retinol
• 97% observed firmer, plumper skin
• 93% saw a more youthful complexion
• 97% noted improvements in skin tone and texture
• 80% witnessed a reduction in fine lines and wrinkles
• 73% experienced reduced pigmentation and age spots.

*Details and results from the various clinical trials are available at www.modernmolecules.com 

Singapore's Exclusive Launch from 28 October 

Consumers can register for early access through a waitlist on modernmolecules.com. Available first in Singapore from 28 October 2024, the serum will be available for purchase online via modernmolecules.com, selected Watsons stores island-wide^[1] as well as e-commerce platforms including Shopee, Lazada, Zalora and TikTok Shop for SGD $49 (35ml bottle).

END

About Modern Molecules 

Modern Molecules is a breakthrough anti-ageing skincare brand from the laboratories of Seoul, Korea. Introducing REGENEXâ„¢. The first modern molecule for ageing that combines revolutionary Spicules, Exosomes and Peptides for 7X better than retinol anti-ageing performance. Once used for the treatment of burns, now harnessed for anti-ageing, it regenerates aged skin back to youth. Discovered and developed by a team of the world's leading Dermatologists, it is clinically proven by the Korean Skin Institute to delay ageing by 5 and a half years and reduce wrinkles by 40%. Modern Molecule's first product, the REGENEXâ„¢ Renewal Serum, will launch in October.

CLINIC BORN. SEOUL MADE. í´ë¦¬ë‹‰ì´ 탄ìƒí–ˆìŠµë‹ˆë‹¤. ì„œìš¸ì´ ë§Œë“¤ì—ˆìŠµë‹ˆë‹¤.

[1] Available at the following Watsons stores: Parkway Parade, NEX, Marina Square, ION Orchard, Ngee Ann City, Causeway Point, Bugis Junction, The Star Vista, Tampines Mall, Tiong Bahru Plaza, Jurong Point JEM, Hougang Mall, Eastpoint Mall, Toa Payoh (HDB), Vivocity, Anchorpoint, Waterway Point, Raffles City, Compass One, Marina Bay Sands, Great World City, Bukit Panjang Plaza, West Mall, Hougang Street 21, 100AM and Westgate.

[1] Available at the following Watsons stores: Parkway Parade, NEX, Marina Square, ION Orchard, Ngee Ann City, Causeway Point, Bugis Junction, The Star Vista, Tampines Mall, Tiong Bahru Plaza, Jurong Point JEM, Hougang Mall, Eastpoint Mall, Toa Payoh (HDB), Vivocity, Anchorpoint, Waterway Point, Raffles City, Compass One, Marina Bay Sands, Great World City, Bukit Panjang Plaza, West Mall, Hougang Street 21, 100AM and Westgate.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **



Korean Clinical Trials Prove Exosomes, Peptides and Spicules Outperforms Retinol in Anti-Ageing



Korean Clinical Trials Prove Exosomes, Peptides and Spicules Outperforms Retinol in Anti-Ageing

Augustus names Benjamin Alexander as Chief Compliance Officer, bringing 15+ years of BSA/AML and regulatory compliance leadership from Column, HSBC, and JPMorgan Chase to architect the compliance framework for the first clearing bank for the AI era

NEW YORK, May 19, 2026 /PRNewswire/ -- Augustus, the company building the world's first clearing bank for the AI era, today announced the appointment of Benjamin Alexander as Chief Compliance Officer. Benjamin joins from Column, where he served as Chief Compliance Officer and BSA/AML Officer, and brings over 15 years of compliance leadership across both global banking institutions and high-growth fintechs.

This appointment follows Augustus's receipt of conditional approval for a national bank charter from the United States Office of the Comptroller of the Currency (OCC), which will enable Augustus to build a clearing bank that is inherently programmable with an AI-native core. Building a new kind of bank requires a new kind of compliance infrastructure. As Augustus prepares to extend its always-on clearing platform to US Dollars — the world's primary reserve currency — the stakes of getting compliance right couldn't be higher.

Benjamin previously re-built Column's compliance infrastructure from the ground up, including their foreign correspondent banking program. Benjamin's further experience at JPMorgan Chase, HSBC and CFSB gives him a vantage point few compliance leaders have: the full stack, from the world's largest correspondent banking networks to the earliest stages of a technology first clearing platform at Column. That combination — large-bank rigor, fintech agility — is precisely what Augustus needs. Augustus is not retrofitting a legacy compliance stack; it is building one from scratch, designed for programmable money, agentic transactions, and 24/7 global operations, and he is the right architect for the job.

"You need to get three things right to nail global clearing for the AI era: the full charter, the intelligent bank core, and an outstanding compliance product," said Ferdinand Dabitz, CEO and Co-Founder of Augustus. "With Benjamin's unique experience, we can turn this compliance platform into a competitive advantage that is always on, made of code and works at the speed of compute."

"After 15 years of navigating legacy systems and institutions, I'm ready to stop retrofitting the old and start building the new. We've reached a rare convergence of banking, stablecoins, and AI— the perfect environment to build a purpose-built compliance stack from scratch," said Benjamin Alexander, Chief Compliance Officer of Augustus.

Benjamin joins a leadership team that includes President Greg Quarles, a former National Bank Examiner and CEO of Green Dot Bank; CFO Joe Schenone, who has successfully transformed two technology companies into regulated banks; Chief Credit Officer Andy Riggs, from the founding team of Brex's Asset Management business; and Chief Risk Officer Kyle Steed, who is a seasoned financial services executive and former bank regulator who was most recently Interim Chief Risk Officer at United Texas Bank.

About Augustus
Augustus is building the first clearing bank for the AI era — an intelligent bank, built on programmable money and AI. Augustus is built to serve global financial institutions, and is already processing billions for market leaders like Kraken today. Augustus was founded in 2022 by Ferdinand Dabitz, Joshua Becker, Simon Wimmer, and Peter Lieck, and has raised $40 million. They're backed by Peter Thiel's Valar Ventures, Creandum, and the founders of companies like Ramp, Deel, and Circle.

CONTACT: press@augustus.com

Augustus names Benjamin Alexander as Chief Compliance Officer, bringing 15+ years of BSA/AML and regulatory compliance leadership from Column, HSBC, and JPMorgan Chase to architect the compliance framework for the first clearing bank for the AI era

NEW YORK, May 19, 2026 /PRNewswire/ -- Augustus, the company building the world's first clearing bank for the AI era, today announced the appointment of Benjamin Alexander as Chief Compliance Officer. Benjamin joins from Column, where he served as Chief Compliance Officer and BSA/AML Officer, and brings over 15 years of compliance leadership across both global banking institutions and high-growth fintechs.

This appointment follows Augustus's receipt of conditional approval for a national bank charter from the United States Office of the Comptroller of the Currency (OCC), which will enable Augustus to build a clearing bank that is inherently programmable with an AI-native core. Building a new kind of bank requires a new kind of compliance infrastructure. As Augustus prepares to extend its always-on clearing platform to US Dollars — the world's primary reserve currency — the stakes of getting compliance right couldn't be higher.

Benjamin previously re-built Column's compliance infrastructure from the ground up, including their foreign correspondent banking program. Benjamin's further experience at JPMorgan Chase, HSBC and CFSB gives him a vantage point few compliance leaders have: the full stack, from the world's largest correspondent banking networks to the earliest stages of a technology first clearing platform at Column. That combination — large-bank rigor, fintech agility — is precisely what Augustus needs. Augustus is not retrofitting a legacy compliance stack; it is building one from scratch, designed for programmable money, agentic transactions, and 24/7 global operations, and he is the right architect for the job.

"You need to get three things right to nail global clearing for the AI era: the full charter, the intelligent bank core, and an outstanding compliance product," said Ferdinand Dabitz, CEO and Co-Founder of Augustus. "With Benjamin's unique experience, we can turn this compliance platform into a competitive advantage that is always on, made of code and works at the speed of compute."

"After 15 years of navigating legacy systems and institutions, I'm ready to stop retrofitting the old and start building the new. We've reached a rare convergence of banking, stablecoins, and AI— the perfect environment to build a purpose-built compliance stack from scratch," said Benjamin Alexander, Chief Compliance Officer of Augustus.

Benjamin joins a leadership team that includes President Greg Quarles, a former National Bank Examiner and CEO of Green Dot Bank; CFO Joe Schenone, who has successfully transformed two technology companies into regulated banks; Chief Credit Officer Andy Riggs, from the founding team of Brex's Asset Management business; and Chief Risk Officer Kyle Steed, who is a seasoned financial services executive and former bank regulator who was most recently Interim Chief Risk Officer at United Texas Bank.

About Augustus
Augustus is building the first clearing bank for the AI era — an intelligent bank, built on programmable money and AI. Augustus is built to serve global financial institutions, and is already processing billions for market leaders like Kraken today. Augustus was founded in 2022 by Ferdinand Dabitz, Joshua Becker, Simon Wimmer, and Peter Lieck, and has raised $40 million. They're backed by Peter Thiel's Valar Ventures, Creandum, and the founders of companies like Ramp, Deel, and Circle.

CONTACT: press@augustus.com

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Following OCC Conditional Approval, Augustus Announces Column's Benjamin Alexander as Chief Compliance Officer